Mylan Plans Half-Priced Generic Version of EpiPen

Mylan NV is answering critics of the $600 price tag on its branded EpiPen with plans for a generic version of the product expected to hit the market in the next few weeks. Bloomberg's Cynthia Koons reports on "Bloomberg Markets." (Source: Bloomberg)

Banks See Declines in Trading Revenue
18:36 - Bloomberg's Laura Keller reports on the performance of the banking sector and how investment banking is weathering a trading slump. She speaks on "Bloomberg Daybreak: Asia." (Source: Bloomberg)
  • Liu Wei on 'Brilliant Ideas'
  • Full Show: Bloomberg Technology (09/19)
  • Full Show: What'd You Miss? (09/19)